These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33908348)

  • 1. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
    Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
    Elife; 2021 Apr; 10():. PubMed ID: 33908348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
    Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
    J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
    Adam AP; Sharenko AL; Pumiglia K; Vincent PA
    J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
    Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
    Elife; 2020 Apr; 9():. PubMed ID: 32312382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src.
    Sjöberg E; Melssen M; Richards M; Ding Y; Chanoca C; Chen D; Nwadozi E; Pal S; Love DT; Ninchoji T; Shibuya M; Simons M; Dimberg A; Claesson-Welsh L
    J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37651195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability.
    Thibeault S; Rautureau Y; Oubaha M; Faubert D; Wilkes BC; Delisle C; Gratton JP
    Mol Cell; 2010 Aug; 39(3):468-76. PubMed ID: 20705246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs.
    Sidibé A; Polena H; Pernet-Gallay K; Razanajatovo J; Mannic T; Chaumontel N; Bama S; Maréchal I; Huber P; Gulino-Debrac D; Bouillet L; Vilgrain I
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H455-63. PubMed ID: 24858856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
    Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
    Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
    Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
    Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide inhibition restores endothelium-dependent dilatation in aging arteries by enhancing impaired adherens junctions.
    Chang F; Flavahan S; Flavahan NA
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H805-H811. PubMed ID: 29351453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric Oxide Increases Arterial Endotheial Permeability through Mediating VE-Cadherin Expression during Arteriogenesis.
    Yang B; Cai B; Deng P; Wu X; Guan Y; Zhang B; Cai W; Schaper J; Schaper W
    PLoS One; 2015; 10(7):e0127931. PubMed ID: 26133549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
    Ha CH; Bennett AM; Jin ZG
    J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF2α signaling inhibits adherens junctional disruption in acute lung injury.
    Gong H; Rehman J; Tang H; Wary K; Mittal M; Chaturvedi P; Zhao YY; Komarova YA; Vogel SM; Malik AB
    J Clin Invest; 2015 Feb; 125(2):652-64. PubMed ID: 25574837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
    Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
    J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca
    Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.
    Li X; Padhan N; Sjöström EO; Roche FP; Testini C; Honkura N; Sáinz-Jaspeado M; Gordon E; Bentley K; Philippides A; Tolmachev V; Dejana E; Stan RV; Vestweber D; Ballmer-Hofer K; Betsholtz C; Pietras K; Jansson L; Claesson-Welsh L
    Nat Commun; 2016 Mar; 7():11017. PubMed ID: 27005951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes.
    Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I
    Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
    Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
    Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.